Jorgen Vestbo
Pulmonary and Respiratory Medicine · 2004–2019
A researcher in the Science corpus: 20 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Pulmonary and Respiratory Medicine — 317 citations into it; #488 of 770 by trust here, #95 by citations
Whom Jorgen Vestbo trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jorgen Vestbo overall
Papers from Jorgen Vestbo's perspective
Ordered by how strongly the researchers Jorgen Vestbo trusts endorse each paper. Same corpus, a different order for every researcher.
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. (European Respiratory Journal)
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (American Journal of Respiratory and Critical Care Medicine)
- Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
- Chronic obstructive pulmonary disease: current burden and future projections (European Respiratory Journal)
- Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis (Thorax)
- Gender and chronic obstructive pulmonary disease: why it matters.
- Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. (American Journal of Respiratory and Critical Care Medicine)
- Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. (American Journal of Respiratory and Critical Care Medicine)
- Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. (American Journal of Respiratory and Critical Care Medicine)
- THE GLOBAL BURDEN OF DISEASE 1990-2020
Their papers
- Characterisation of COPD heterogeneity in the ECLIPSE cohort (2010) — 1,244 citations
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (2019) — 1,914 citations
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017) — 643 citations
- Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report (2017) — 1,216 citations
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary (2017) — 3,443 citations
- Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline (2017) — 596 citations
- Treatable traits: toward precision medicine of chronic airway diseases (2016) — 1,002 citations
- Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. (2016) — 831 citations
- Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. (2015) — 1,071 citations
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012) — 850 citations
- Changes in forced expiratory volume in 1 second over time in COPD. (2011) — 1,005 citations
- Chronic obstructive pulmonary disease phenotypes: the future of COPD. (2010) — 1,052 citations
- Susceptibility to exacerbation in chronic obstructive pulmonary disease. (2010) — 2,914 citations
- Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. (2008) — 809 citations
- Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) (2008) — 787 citations
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) — 3,539 citations
- Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. (2007) — 3,269 citations
- Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. (2006) — 664 citations
- Developing COPD: a 25 year follow up study of the general population (2006) — 634 citations
- [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease]. (2004) — 1,259 citations